BlueCrest Capital Management (UK)’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,800	Closed	-$192K	–	579
2014 Q1	$192K	Buy	+13,800	New	+$192K	0.01%	402